Gaomai Pharmaceutical was established on August 8, 2018, specializing in providing one-stop solutions in the field of skin health. With the development and industrialization of transdermal drug delivery technology as the core, it possesses a prescription reverse engineering technology platform, an industrialization process technology platform, and an in vitro evaluation technology platform. Deeply layout sales attributes and focus on light medical aesthetic drugs and medical devices.
The company currently operates under a dual-wheel drive model of CRO and MAH, serving as a production plant for strategic cooperative factories. And always adhere to the three-step strategy of high-end imitation, the combination of imitation and creation for technological upgrading, and independent innovation; We have successfully facilitated multiple varieties to obtain production approval documents for consistency evaluation.
Based on the external application technology of chemical drugs, it expands the field of external application of traditional Chinese medicine. Through mature academic promotion, online operation and OTC channel network, it deeply cultivates the skin health market and is committed to building a leading enterprise in external medicine that combines professionalism and consumer medical characteristics.